Biblio

Author Title [ Type(Desc)] Year
Filters: Author is He, Jing  [Clear All Filters]
Journal Article
He J, Yan A, Chen B, Huang J, Kee K. 3D genome remodeling and homologous pairing during meiotic prophase of mouse oogenesis and spermatogenesis. Dev Cell. 2023.
Yu Q, Wang D, Wen X, Tang X, Qi D, He J, Zhao Y, Deng W, Zhu T. Adipose-derived Exosomes Protect the Pulmonary Endothelial Barrier in Ventilator-induced Lung Injury by Inhibiting the TRPV4/Ca2+ Signaling Pathway. Am J Physiol Lung Cell Mol Physiol. 2020.
He J, Tian X, Luo T, Zou R, Yin Z, Chen K, Zhu C, He X. Allogeneic hematopoietic stem cell transplantation corrects ligase IV deficiency. Transpl Immunol. 2023:101897.
Zhang N, Wang Y, Zhang J, Guo J, He J. Controlled domain gels with a biomimetic gradient environment for osteochondral tissue regeneration. Acta Biomater. 2021.
Sun X, Dai Y, He J, Li H, Yang X, Dong W, Xie X, Wang M, Xu Y, Lv L. D-mannose induces TFE3-dependent lysosomal degradation of EGFR and inhibits the progression of NSCLC. Oncogene. 2023.
Deng M, He J, Hao C, Guo Y, Si H, Deng X, Zhang C, Li S, Yao S, Ren W, et al. Effect of exosomes derived from bone marrow mesenchymal stem cells on programmed cell death in blast-induced lung injury in rats. Shock. 2023.
Deng H, Wang Y, Yin Y, Shu J, Zhang J, Shu X, Wu F, He J. Effects of matrix viscoelasticity on cell-matrix interaction, actin cytoskeleton organization, and apoptosis of osteosarcoma MG-63 cells. J Mater Chem B. 2023.
Xu J, Wang Y, He J, Xia W, Zou Y, Ruan W, Lou Q, Li Y, Li H, Chen W. Generation of a human Charcot-Marie-Tooth disease type 1B (CMT1B) iPSC line, ZJUCHi001-A, with a mutation of c.292C>T in MPZ. Stem Cell Res. 2019;35:101407.
Xu J, Fu Y, Xia W, He J, Zou Y, Ruan W, Lou Q, Li Y, Pan J, Li H, et al. Generation of induced pluripotent stem cell line, ZJUCHi002-A, from Charcot-Marie-Tooth disease type 2A (CMT2A) patient with a mutation of c.752C>T in MFN2. Stem Cell Res. 2019;36:101411.
He J, Wang Z, Ao C, Tu C, Zhang Y, Chang C, Xiao C, Xiang E, Rao W, Li C, et al. A highly sensitive and specific Homo1-based real-time qPCR method for quantification of human umbilical cord mesenchymal stem cells in rats. Biotechnol J. 2024;19(2):e2300484.
Zhang K, Zheng S, Wu J, He J, Ouyang Y, Ao C, Lang R, Jiang Y, Yang Y, Xiao H, et al. Human umbilical cord mesenchymal stem cell-derived exosomes ameliorate renal fibrosis in diabetic nephropathy by targeting Hedgehog/SMO signaling. FASEB J. 2024;38(7):e23599.
Liu Y, Li C, Wang S, Guo J, Guo J, Fu J, Ren L, An Y, He J, Li Z. Human Umbilical Cord Mesenchymal Stem Cells Confer Potent Immunosuppressive Effects in Sjögren's Syndrome by Inducing Regulatory T Cells. Mod Rheumatol. 2019:1-25.
Deng T, He J, Yao Q, Wu L, Xue L, Wu M, Wu D, Li C, Li Y. Human Umbilical Cord Mesenchymal Stem Cells Improve Ovarian Function in Chemotherapy-Induced Premature Ovarian Failure Mice Through Inhibiting Apoptosis and Inflammation via a Paracrine Mechanism. Reprod Sci. 2021.
Chen B, Zhu G, Yan A, He J, Liu Y, Li L, Yang X, Dong C, Kee K. IGSF11 is required for pericentric heterochromatin dissociation during meiotic diplotene. PLoS Genet. 2021;17(9):e1009778.
Liang J, Wang N, He J, Du J, Guo Y, Li L, Wu W, Yao C, Li Z, Kee K. Induction of Sertoli-like cells from human fibroblasts by NR5A1 and GATA4. Elife. 2019;8.
He J, Yang Y-M, Liu L, Wang D. [Influence of maternal and infant factors on CD34 hematopoietic stem/progenitor cells in umbilical cord blood]. Zhongguo Dang Dai Er Ke Za Zhi. 2021;23(1):43-48.
He J, Zhang N, Zhang J, Jiang B, Wu F. Migration critically meditates osteoblastic differentiation of bone mesenchymal stem cells through activating canonical Wnt signal pathway. Colloids Surf B Biointerfaces. 2018;171:205-213.
He J, Wu F, Wang D, Yao R, Wu Y, Wu F. Modulation of cationicity of chitosan for tuning mesenchymal stem cell adhesion, proliferation, and differentiation. Biointerphases. 2015;10(4):04A304.
Zhao Y, Li Y, He J, Li M, Yao X, Yang H, Luo Z, Luo P, Su M. Nanointegrative Glycoengineering-Activated Necroptosis of Triple Negative Breast Cancer Stem Cells Enables Self-Amplifiable Immunotherapy for Systemic Tumor Rejection. Adv Healthc Mater. 2023:e2303337.
Chen Y, Miao L, Lin H, Zhuo Z, He J. The role of m6A modification in pediatric cancer. Biochim Biophys Acta Rev Cancer. 2022:188691.
Lin M, He J, Zhang X, Sun X, Dong W, Zhang R, Xu Y, Lv L. Targeting fibrinogen-like protein 1 enhances immunotherapy in hepatocellular carcinoma. J Clin Invest. 2023;133(9).